Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
7.12
0.00 (0.00%)
At close: Mar 18, 2026, 4:00 PM EDT
6.98
-0.14 (-1.97%)
After-hours: Mar 18, 2026, 4:59 PM EDT
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $340.11 million as of March 18, 2026. Its market cap has increased by 274.77% in one year.
Market Cap
340.11M
Enterprise Value
180.00M
1-Year Change
274.77%
Ranking
Category
Stock Price
$7.12
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $340.11M, a decrease of -15.65%. That is a compound annual growth rate of -3.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 340.11M | 78.09% |
| Dec 31, 2025 | 190.98M | 57.83% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
| Aug 10, 2021 | 403.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicycle Therapeutics | 353.41M |
| PepGen | 351.80M |
| Armata Pharmaceuticals | 349.13M |
| Opus Genetics | 341.52M |
| Minerva Neurosciences | 339.70M |
| AC Immune | 337.89M |
| Nautilus Biotechnology | 334.71M |
| NovaBridge Biosciences | 332.04M |